The role of B-cell-specific activator protein in the response of malignant B-1 cells to LPS

Experimental Cell Research

Volumn 264, Issue 2, 2001, Pages 233-243

  Zhang, Ming ^a   Chong, Siew Yen ^a   Raveche, Elizabeth S ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGENIC AGENT;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; DNA BINDING; MALIGNANT TRANSFORMATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0035298104     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5122     Document Type: Article

References (63)

1. B-chronic lymphocytic leukemia: A malignancy of anti-self B cells
2. B-1 cells are made, not born
3. The "clonal selection hypothesis" and current concepts of B cell tolerance
4. Clonal selection and learning in the antibody system
5. Structure and function of natural antibodies
6. The development and repertoire of B-1 cells (CD5 B-Cells)
7. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition
8. Administration ofinterleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice
9. De novo development and self-replenishment of B cells
10. The NZB mouse as a model for CLL
11. Ly-1 B cell clones similar to human CLL routinely develop in older normal mice and young autoimmune NZB related animals
12. Clonal expansion of abnormal B cells in old NZB mice
13. A cultured malignant B-1 line serves as a model for Richter's syndrome
14. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL
15. Cellular and molecular basis of B-cell clonal expansions
16. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition
17. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BASP
18. BSAP: A key regulator of B cell development and differentiation
19. Regulation of 3′ IgH enhancers by a common set of factors, including kappa B-binding proteins
20. The role of BSAP in immunoglobulin isotype switching and B-cell proliferation
21. The transcription factor BSAP (NF-HB) is essential for immunoglobulin germ-line epsilon transcription
22. B cell differentiation: Role of E2A and Pax5/BSAP transcription factors
23. The B cell-specific transcription factor BSAP regulates B cell proliferation
24. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes
25. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells
26. Specific activation of the cysteine protease CPP32 during the negative selection of T cells in the thymus
27. Private pathways to a common death
28. A rapid simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
29. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
30. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
31. Rapid colorimetric assay for cell growth and survival modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
32. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
33. Essential functions of Pax5 (BSAP) in pro-B cell development: Difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus
34. A nuclear DNA-binding protein expressed during early stages of B cell differentiation interacts with diverse segments within and 3′ of the Ig H chain gene cluster
35. The growth regulatory role of BSAP in NZB malignant B-1 cells
36. Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease
37. Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines
38. Expression of the c-myc proto-oncogene in multiple myeloma and chronic lymphocytic leukemia - An in situ analysis
39. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice
40. Overexpression of cyclin D2 in chronic B-cell malignancies
41. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus
42. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
43. Fas and Fas ligand: lpr and gld mutations
44. The role of bcl-2 in the natural history of B-CLL
45. Defective apoptosis due to Bcl-2 overexpression may explain why B-CLL cells accumulate in GO
46. Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells
47. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies
48. Cytokines and intracellular signals involved in the regulation of B-CLL proliferation
49. Cytokine gene expression in B-CLL: Evidence of constitutive IL-8 mRNA expression and secretion of biologicallly active IL-8 protein
50. Maintenance of CD5+ B cells at an early developmental stage by interleukin-5: Evidence from immunoglobulin gene usage in interleukin-5 transgenic mice
51. IL-10 production in a CD5+B cell lymphoma arising in a anti-CD4 monoclonal antibody treated SJL
52. Endotoxin shock in antibody-deficient mice: Unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide
53. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse
54. An explanation for the defect in secretion of IgM Mott cells and their predominant occurrence in the Ly-1 B cell compartment
55. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype
56. Integrated control of cell proliferation and cell death by the c-myc oncogene
57. Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB x NZW)F1 mice
58. Key differentiation steps in normal B cells and in myeloma cells
59. Continuous administration of anti-IL-10 antibodies delays onset of autoimmunity in NZB/W F1 mice
60. Differentiation and apoptosis of human germinal center B-lymphocytes
61. Role of cytokines in human B lymphocyte growth and differentiation
62. Pax-5/BSAP: Regulator of specific gene expression and differentiation in B lymphocytes
63. Transcription factor BSAP is differentially expressed in B cells and subsets of B-cell lymphomas